|
Market Closed -
Borsa Istanbul
11:08:00 2026-10-26 EDT
|
5-day change | 1st Jan Change | ||
| 73.45 TRY | +1.24% |
|
-3.80% | +17.15% |
| Market Cap | 14.69B 295M 264M 244M 221M 414M 28.09B 421M 2.94B 1.16B 1.11B 1.08B 46.52B | P/E 2024 |
226x | P/E 2025 | -15.5x |
|---|---|---|---|---|---|
| Enterprise Value | 17.08B 343M 307M 284M 257M 481M 32.66B 489M 3.42B 1.35B 1.29B 1.26B 54.08B | EV / Sales 2024 |
1.27x | EV / Sales 2025 | 0.78x |
| Free-Float |
17.78% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.24% | ||
| 1 week | -3.80% | ||
| Current month | -18.48% | ||
| 1 month | -24.86% | ||
| 3 months | -2.84% | ||
| 6 months | +8.90% | ||
| Current year | +17.15% |
| 1 week | 69.7 |  | 77.3 |
| 1 month | 69.7 | | 96.85 |
| Current year | 57.5 | | 109.3 |
| 1 year | 57.5 | | 109.3 |
| 3 years | 51 | | 109.3 |
| 5 years | 22.46 | | 109.3 |
| 10 years | 3.08 | | 109.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Philipp Haas
CEO | Chief Executive Officer | - | 2006-07-13 |
Alper Acindi
DFI | Director of Finance/CFO | - | 2025-10-31 |
Mesut Çetin
DFI | Director of Finance/CFO | 47 | 2008-03-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Philipp Haas
CHM | Chairman | - | 2006-07-13 |
Aysecik Haas
BRD | Director/Board Member | - | 2013-05-21 |
Tuncay Cem Akkus
BRD | Director/Board Member | - | 2015-04-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.24% | -3.80% | +3.67% | -11.51% | 292M | |
| +0.45% | +3.13% | +54.96% | +125.16% | 1,135B | |
| +0.94% | +4.93% | +39.86% | +78.72% | 635B | |
| +0.39% | +1.44% | +25.77% | +97.48% | 505B | |
| +1.43% | +4.31% | +46.20% | +67.12% | 378B | |
| -3.21% | -2.10% | +60.72% | +33.22% | 358B | |
| -0.41% | +2.64% | +22.48% | +49.82% | 295B | |
| +0.23% | +3.66% | +2.57% | +23.69% | 266B | |
| +1.22% | +4.63% | +52.40% | +64.85% | 237B | |
| +1.70% | +3.67% | +31.21% | +102.15% | 193B | |
| Average | +0.37% | +0.94% | +33.98% | +63.07% | 400.39B | |
| Weighted average by Cap. | +0.42% | +1.63% | +41.40% | +83.60% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 15.46B 311M 278M 257M 233M 436M 29.56B 443M 3.09B 1.22B 1.17B 1.14B 48.95B | 19.25B 387M 346M 320M 290M 542M 36.8B 551M 3.85B 1.52B 1.45B 1.42B 60.94B |
| Net income | 69.42M 1.4M 1.25M 1.15M 1.04M 1.96M 133M 1.99M 13.89M 5.49M 5.24M 5.12M 220M | -807M -16.22M -14.5M -13.42M -12.15M -22.74M -1.54B -23.11M -161M -63.86M -60.87M -59.57M -2.56B |
| Net Debt | 4B 80.3M 71.8M 66.43M 60.15M 113M 7.64B 114M 799M 316M 301M 295M 12.65B | 2.39B 48.03M 42.95M 39.73M 35.98M 67.33M 4.57B 68.44M 478M 189M 180M 176M 7.57B |
Employees
3,057
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-26 | TRY 73.45 | +1.24% | 165,002 |
| 26-10-23 | TRY 72.55 | -0.14% | 264,757 |
| 26-10-22 | TRY 72.65 | -1.36% | 306,600 |
| 26-10-21 | TRY 73.65 | -4.47% | 304,756 |
| 26-10-20 | TRY 77.10 | +1.98% | 353,944 |
- Stock Market
- Stocks
- DEVA Stock
Select your edition
All financial news and data tailored to specific country editions
